Effects of stress and behavioral interventions in hypertension: the rise and fall of omapatrilat

J Clin Hypertens (Greenwich). 2002 Sep-Oct;4(5):371-3. doi: 10.1111/j.1524-6175.2002.01506.x.

Author

Thomas G Pickering¹

Affiliation

¹ Integrative and Behavioral Cardiovascular Health Program, Zena and Michael Wiener Cardiovascular Institute, Mt. Sinai School of Medicine, New York, NY 10029, USA.

No abstract available

MeSH terms

Angioedema / etiology
Angiotensin-Converting Enzyme Inhibitors / adverse effects*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antihypertensive Agents / adverse effects*
Antihypertensive Agents / therapeutic use
Drug Approval
Humans
Hypertension / drug therapy*
Hypertension / etiology
Neprilysin / antagonists & inhibitors*
Pyridines / adverse effects*
Pyridines / therapeutic use
Thiazepines / adverse effects*
Thiazepines / therapeutic use
United States
United States Food and Drug Administration

Substances

Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Pyridines
Thiazepines
omapatrilat
Neprilysin